Sign In

Kenneth Hallenbeck

Senior Scientific Researcher at Genentech

Kenneth Hallenbeck is a Senior Scientific Researcher at Genentech, where he is part of the Department of Early Discovery Biochemistry. His research focuses on the development of combinatorial macrocyclic peptide libraries aimed at creating therapeutics for challenging cellular targets, often referred to as "undruggable" .1 Hallenbeck has been involved in innovative approaches to incorporate β-amino acids into macrocyclic peptides, enhancing their diversity and potential therapeutic applications .1

He holds a Ph.D. in Pharmaceutical Sciences from the University of California, San Francisco, and has contributed significantly to the field of drug discovery through his work with DNA-encoded technologies and robotics .46 Hallenbeck's expertise includes chemical biology and medicinal chemistry, particularly in relation to cancer and neurodegenerative diseases .26

In addition to his research contributions, Hallenbeck is active on LinkedIn, where he shares insights related to his work and interests in scientific writing .35

Highlights

Jul 30 · pharm.ucsf.edu
People · Small Molecule Discovery Center (SMDC) · UCSF

Related Questions

What are Kenneth Hallenbeck's main research interests?
How has Kenneth Hallenbeck contributed to drug discovery at Genentech?
What specific projects has Kenneth Hallenbeck worked on at Genentech?
What is Kenneth Hallenbeck's educational background?
How long has Kenneth Hallenbeck been at Genentech?
Kenneth Hallenbeck
Kenneth Hallenbeck, photo 1
Kenneth Hallenbeck, photo 2
Add to my network

Location

South San Francisco, California